July 29, 2014
MOUNTAIN VIEW, CA –– 23andMe, the leading personal genetics company, has received from the National Institutes of Health (NIH) a grant totaling $1,367,504 for a two-year project to support the further development of 23andMe’s web-based database and research engine for genetic discovery. Specifically, the grant supports four areas of development: •Refinement of web-based surveys to [...]
July 29, 2014
Milford, Massachusetts -- KPL, a SeraCare Company, today announced the addition of three new products to its growing line of BacTrace antibodies: BacTrace® Antibody Coated Latex Beads, BacTrace® STEC Antibodies, and BacTrace® Salmonella CSA-Plus Antibodies. These tools are designed for use by researchers and developers of foodborne pathogen assays. As polyclonals, the BacTrace antibodies can [...]
FEI Adds Phase Plate Technology and Titan Halo TEM to Its Structural Biology Product Portfolio
July 28, 2014
HILLSBORO, Ore.-- FEI (Nasdaq:FEIC) announced two new products for cryo-electron microscopy applications: a new phase plate solution and the Titan Halo™ transmission electron microscope (TEM). The phase plate is a stable, durable solution to increase the contrast of sensitive biological samples and is available on most TEM platforms from FEI. The Titan Halo TEM provides [...]
July 28, 2014
BILLERICA, Mass.-- Bruker (NASDAQ:BRKR) today announced that it has acquired Vutara Incorporated, a technology leader in high-speed, three-dimensional (3D), super-resolution fluorescence microscopy for life science applications. Transaction details were not disclosed. Vutara’s estimated revenue for the full year 2014 is expected to be approximately $2 million. The acquisition further strengthens Bruker’s biological microscopy business by [...]
INTEGRA PIpette Streamlines Screening of Novel Protein Therapeutics
July 28, 2014
Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins. DARPins are a next generation of protein therapeutics combining the advantages of antibodies and small molecule drugs. High target specificity [...]
Thermo Fisher Scientific Launches LC-MS-Based Class I Medical Devices
July 28, 2014
CHICAGO -- Clinical laboratories now have access to a new high-performance liquid chromatograph, mass spectrometer and LC-MS software designed and manufactured as FDA Class I devices to be components of laboratory-developed tests for analyzing patient samples. The Thermo Scientific Prelude MD HPLC utilizes TurboFlow technology to reduce manual sample clean-up steps and variability. The instrument [...]
ZEISS Launches Mineral Analysis Solution for Mining Industry
July 28, 2014
JENA/Germany -- Today, ZEISS launches Mineralogic Mining to provide fully quantitative evaluation during ore exploration, recovery and tailings-control processes. The new solution will enable the mining industry to maximize the recovery of natural resources. ZEISS Mineralogic Mining combines a mineral analysis engine with a scanning electron microscope and energy dispersive spectrometers to provide automated analysis, [...]
Bio-Rad Introduces SureBeads™ Magnetic Bead Immunoprecipitation System
July 28, 2014
Hercules, CA — — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced that it has launched its SureBeads Magnetic Bead System, which provides researchers with a faster and easier alternative to agarose beads for immunoprecipitation for as low as half the price of other available magnetic bead systems. Benefits include reduced antibody consumption and [...]
New Chlamydia and Gonorrhea Assays on the BD Viper™ LT System Receive FDA 510k Clearance
July 28, 2014
BALTIMORE -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE: BDX) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTec™ Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay on the BD Viper™ LT [...]
July 28, 2014
Hilden, Germany, and London, U.K. -– QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced a collaboration agreement with AstraZeneca PLC (LSE, NYSE and OMX: AZN) for the co-development and commercialization of a liquid biopsy-based companion diagnostic to be paired with IRESSA, AstraZeneca’s targeted therapy for non-small cell lung cancer (NSCLC). The project builds on [...]
